Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma

Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma

US Patent 7807629 · Granted Oct 5, 2010

Estimated economic value: $50,560,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compoun2022
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypert2018
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypert2017
Use of bradykinin and related B2R agonists to treat ocular hypertension and glau2012
Bradykinin receptor agonists and uses thereof to treat ocular hypertension and g2012
Use of non-peptidic bradykinin receptor agonists to treat ocular hypertension an2012
Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-med2011
Method for treating glaucoma comprising administering α-lipoic acid2010
(Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating gl2010
Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders2007
Methods of treating dry eye disorders2007
Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders2006